07:00 , Jul 23, 2012 |  BioCentury  |  Emerging Company Profile

Oncotide: SETting up phosphatases

Oncotide Pharmaceuticals Inc. believes it has found a way to deactivate the phosphorylation that is a driver of oncogenic signaling, an approach that could provide an alternative or add-on to kinase inhibitors for blocking growth...
08:00 , Dec 16, 2010 |  BC Innovations  |  Distillery Therapeutics

Indication: Various

This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Various Colitis; inflammatory bowel disease (IBD) Apolipoprotein E (APOE) Studies in mice suggest that the APOE mimetic peptide COG112 could help treat...